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Abstract. This study describes the development and 
use of a specific method for disassembling intermediate 
filament (IF) networks in living cells. It takes advantage 
of the disruptive effects of mimetic peptides derived 
from the amino acid sequence of the helix initiation 1A 
domain of IF protein chains. The results demonstrate 
that at 1:1 molar ratios, these peptides disassemble vi- 
mentin IF into small oligomeric complexes and mono- 
mers within 30 min at room temperature in vitro. Upon 
microinjection into cultured fibroblasts, these same 
peptides induce the rapid disassembly of IF networks. 
The disassembly process is accompanied by a dramatic 
alteration in cell shape and the destabilization of micro- 
tubule and actin-stress fiber networks. These changes in 
cell shape and IF assembly states are reversible. The re- 
sults are discussed with respect to the roles of IF in cell 
shape and the maintenance of the integrity and me- 
chanical properties of the cytoplasm, as well as the sta- 
bility of the other major cytoskeletal systems. 
I 
NTERMEDIATE filaments  (IF) 1 are  major fibrous  pro- 
teins that are found in the nucleoplasm and the cyto- 
plasm of most types of animal cells. In the cytoplasm, 
they are usually organized into complex arrays of 10-nm 
diameter cytoskeletal IF that are prevalent in the perinu- 
clear region, where they frequently form a cage that sur- 
rounds and appears to position the nucleus. In this region, 
individual IF appear to be attached to the outer nuclear 
envelope membrane or to nuclear pore complexes (Skalli 
and Goldman, 1991).  Continuous with this perinuclear ar- 
ray, IF extend radially through the cytoplasm, eventually 
forming  close  associations  with  the  cell  surface.  Fre- 
quently, these membrane associations are concentrated in 
regions  containing  desmosomes,  hemidesmosomes,  and 
other types of adhesion sites (Green and Jones, 1990). 
The overall organization of cytoskeletal IF networks, as 
well as their in vitro properties, suggests that they link the 
nuclear and cell surfaces and that they are involved in nu- 
merous cell functions, including the  maintenance  of the 
overall integrity of cytoplasm (Janmey et al., 1991; Wang 
et al.,  1993)  and cell shape (Goldman and  Knipe, 1973). 
These latter roles are supported by the finding that some 
blistering skin diseases  are caused by point mutations in 
keratins that have been related to structural alterations in 
IF, changes in the shape of individual keratinocytes, and 
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the loss of mechanical properties of skin (Coulombe et al., 
1991; Chipev et al., 1992; Fuchs and Coulombe, 1992; Lane 
et al., 1992; Steinert et al.,  1994). The resistance to break- 
age of vimentin IF under conditions of high strain in vitro 
also supports their role in providing cells with resilience to 
mechanical stress in vivo (Janmey et al., 1991). 
Based on their mechanical properties, as well as their in- 
solubility in vitro, IF have long been thought to be very 
stable cytoskeletal elements relative to other cytoskeletal 
systems such as microtubules or microfilaments (Skalli et al., 
1992). However, it has recently been shown that, at least in 
actively growing cultured cells, IF are in fact very dynamic 
structures  in  vivo. For example,  at  the  posttranslational 
level, polymerized vimentin and keratin IF can incorpo- 
rate microinjected unpolymerized subunits in living fibro- 
blasts and epithelial cells (Vikstrom et al.,  1989; Miller et 
al.,  1993). Experiments involving FRAP also demonstrate 
that a steady state equilibrium exists between soluble IF 
subunits  and  polymerized IF in  several  cell types  (Vik- 
strom et al.,  1992; Okabe et al., 1993). These in vivo stud- 
ies of IF dynamics have also been supported by fluores- 
cence  energy  transfer  experiments  carried  out  in  vitro 
(Angelides et al.,  1989).  Furthermore, it has been shown 
that IF exhibit rapid organizational and biochemical changes 
following various stimuli such as heat shock (Welch and 
Suhan,  1985), phosphorylation after exposure to growth 
factors (Baribault et al.,  1989),  and the transient associa- 
tion of IF with protein kinase C in response to a signal at 
the cell surface (Spudich et al.,  1992). These findings have 
implicated IF in dynamic roles in several physiological ac- 
tivities, including signal transduction (Skalli et al., 1992). 
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namic nature. For example, biochemical- and metabolic- 
labeling studies  suggest that  IF protein synthesis occurs 
continuously and that newly synthesized subunits are in- 
corporated into IF at both the co- and posttranslational 
levels (Isaacs et al.,  1989; Ngai et al., 1990;  Sarria et al., 
1990).  However, the  pools of soluble  subunits,  whether 
they are newly synthesized or not, are very small, as indi- 
cated by the fact that the vast majority of IF protein is pel- 
letable in cell-free preparations (Skalli et al., 1992). Other 
evidence supporting the dynamic nature of IF assemblies 
in vivo comes from transient transfection studies that dem- 
onstrate that  the insertion of mutant polypeptide chains 
into endogenous polymerized networks have disruptive ef- 
fects  leading  to  their  disassembly  (Albers  and  Fuchs, 
1989). 
There is considerable evidence in support of a role for 
phosphorylation in regulating at least some of the dynamic 
properties of IF in vivo (Skalli et al., 1992). This evidence 
includes the finding that the hyperphosphorylation of IF 
proteins is  accompanied frequently by their disassembly. 
For example, during mitosis in many types of eukaryotic 
cells,  nuclear  breakdown  is  accompanied  by the  hyper- 
phosphorylation and coincident disassembly of the Type V 
IF polymer, the nuclear lamins (Moir and Goldman, 1993). 
In BHK-21 cells, it has been shown that vimentin IF disas- 
semble during mitosis and that this alteration in the state 
of polymerization is regulated by phosphorylation (Chou 
et al.,  1990; Chou et al.,  1996).  In other cell types, a more 
localized disassembly of cytoskeletal IF due to phosphory- 
lation appears to take place in the cleavage furrow during 
cytokinesis  (Nishizawa  et  al.,  1991).  In  addition,  it  has 
been shown that vimentin IF are rapidly hyperphosphory- 
lated and disassembled in cells exposed to phosphatase in- 
hibitors, suggesting that IF assembly states in interphase 
cells are regulated by kinase/phosphatase equilibria (Eriks- 
son et al., 1992a). In vitro studies support these in vivo ob- 
servations, as numerous kinases phosphorylate and disas- 
semble IF in cell-free preparations (for a review, see Skalli 
et al., 1992; Eriksson et al., 1992b). 
Other evidence supporting the dynamic properties of IF 
has been derived from the use of synthetic peptides whose 
sequences are derived from the highly conserved 2B rod 
domain segment of keratin IF chains. In vitro, these pep- 
tides have been shown to interfere with keratin IF assem- 
bly and to promote the disassembly of preformed IF (Hat- 
zeld and Weber, 1992; Kouklis et al.,  1993; Steinert et al., 
1993c).  In  addition,  it has  been  observed that synthetic 
peptides corresponding to the 1A rod domain segment (or 
helix initiation region) (Steinert et al., 1993a; Steinert et al., 
1993c) and the H1 subdomain immediately before the be- 
ginning of the 1A segment of Type II keratins (Chipev et al., 
1992; Steinert and Parry, 1993) also interfere with keratin 
IF assembly and structure in vitro. These in vitro studies 
are of interest because they represent the first report of re- 
agents  that  can  alter  IF structure  under  nondenaturing 
conditions. A logical extension of these studies is to deter- 
mine whether these peptides may also be used to manipu- 
late the dynamic properties of IF in vivo. To this end, we 
have developed procedures for testing the use of specific 
IF peptides to study the functions of IF in live cells. In this 
study, we present experimental evidence that 1A peptides 
alter the state of assembly of vimentin IF after their micro- 
injection into cultured cells. The consequences of this dis- 
ruption of IF in vivo are very substantial in that they lead 
to significant alterations in cell shape, the general organi- 
zation and integrity of the cytoplasm, and the destabiliza- 
tion of other cytoskeletal systems. The results indicate that 
these reagents can be used as reversible inhibitors of IF 
structure and function. 
Materials and Methods 
Vimentin IF Assembly Assays In Vitro 
Human vimentin was produced in Escherichia coli and purified by a com- 
bination  of column chromatography and  assembly/disassembly in  vitro 
(see Chou et al., 1996). The purified protein was stored frozen (-80°C) in 
unpolymerized form in 2 mM phosphate buffer. For assembly of IF, fro- 
zen aliquots of the protein were precipitated at pH 5.0 with 0.1 M sodium 
acetate and subsequently dissolved in a solution containing 8 M urea, 25 
mM Tris-HCl, pH 7.6, 5 mM DTT, and 1 mM EDTA. Vimentin IF were 
assembled from this solution at a concentration of 0.5 mg/ml by dialysis 
against vimentin IF assembly buffer (AB) containing 10 mM triethanol- 
amine-HCl, pH 8.0, and 0.15 M KCI (Steinert et al.,  1993b). In some ex- 
periments, aliquots of vimentin at the same concentration were dialyzed 
against AB devoid of KCI. Under these conditions, the protein did not as- 
semble into IF but rather remained in the form of small oligomers (Stein- 
ert et al., 1981; Steinert et al., 1993b). 
Synthetic Peptides 
The following  peptides were synthesized and purified by HPLC using es- 
tablished procedures (Chipev et al.,  1992; Steinert et al.,  1993a).  These 
peptides were derived from the published sequences (single  letter amino 
acid  code)  for human vimentin (Ferrari et  al.,  1986), human keratin  1 
(Zhou et al., 1988), and human keratin 10 (Johnson et al., 1985). The resi- 
dues were numbered according to the system of Conway and Parry (1988) 
as follows: vimentin 1A (residues 1-35): KVELQELNDRFANYIDKVR- 
FLEQQNKILLAELEQL (~mol wt 4223); keratin 10 1A (residues 1-35): 
RVTQMNLNDRLASLYDKVRALEESNYELEGKIKEW  (~mol  wt 
4140);  keratin  10  1A  (residues  1-18):  RVTQMNLNDRLASLYDKV 
(~mol wt 2136); and control keratin 10 1A (residues 1-18, mutant R10H; 
see  Steinert  et  al.,  1993c):  RVTQMNLNDHLASYLDKV  (~mol  wt 
2118). 
Following purification by HPLC,  peptide concentrations were deter- 
mined by amino acid analysis as previously described (Chipev et al., 1992; 
Steinert et al.,  1993a).  Peptides were stored in aliquots following lyoph- 
ilization.  Peptides were dissolved in the  buffers described  below for in 
vitro assembly/disassembly  assays or in microinjection buffer (see below) 
for the in vivo assays just before use, Fresh aliquots of peptides were pre- 
pared at the beginning of each day. 
IF Disassembly and Assembly Experiments Utilizing 1A 
Peptides In Vitro 
The synthetic 1A peptides were dissolved in AB in order to achieve  a final 
concentration of 2-3 mg/ml. Aliquots of peptides were then added to sus- 
pensions of polymerized vimentin IF (0.25 ml) so as to achieve 0.1-3-fold 
molar ratios. The reactions were allowed to proceed at room temperature 
and  samples were taken  at time intervals.  In some cases,  reactions be- 
tween  peptide  and  polymer were  terminated  by  treatment  with  0.7% 
aqueous uranyl acetate for negative staining and then examined by trans- 
mission electron microscopy (Steinert et al., 1993a). In other cases, the re- 
actions were stopped by the addition of glutaraldehyde as a cross-linking 
agent at a final concentration of 0.05%.  Cross-linking was allowed to pro- 
ceed for 5 min at room temperature. Samples were then boiled in sample 
buffer used for polyacrylamide gel electrophoresis and aliquots were run 
on 3.75-1%5 % gradient gels (Steinert et al., 1993b). In other experiments, 
peptides were added to oligomeric forms of vimentin in AB without KC1. 
After thorough mixing by mild mechanical agitation, KCI was added to a 
final  concentration of 0.15 M to promote IF polymerization. During the 
assembly reaction, aliquots were removed at time intervals and examined 
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(Steinert et al., 1993b). 
In vitro Assembly of Microtubules and F-Actin 
For control experiments, tubulin was prepared from mouse brain tissue as 
described in Borisy et al. (1975) and retained in unpolymerized form in a 
buffer of 50 mM MES, pH 6.5, 1 mM EDTA, 0.5 mM MgSO4. Assembly 
into microtubules in vitro was achieved upon addition of GTP to a final 
concentration of 0.5 mM at 37°C in the absence or presence of a 1-10-fold 
molar excess of the 1A peptides. Stock solutions of the peptides were dis- 
solved at a concentration of 3 mg/ml in the same buffer. 
Nonmuscle actin  was prepared from new born mouse epidermis as de- 
scribed elsewhere (McGuire et al., 1977) and retained in the G-actin form 
at 0.5  mg/ml in a  solution containing 2 mM Tris-HC1,  pH 8.0, 0.2  mM 
ATP, 0.5 mM DTT, and 0.5 mM CaC12. The 1A peptides were dissolved in 
the same buffer and added at 1-10-fold  molar ratios. Polymerization of ac- 
tin in the absence or presence of the peptide was achieved by the addition 
of KC1 to a final concentration of 0.2 M at room temperature. In some as- 
says, F-actin was decorated with heavy meromyosin prepared from mouse 
skeletal muscle as described elsewhere (Ishikawa et al., 1969). The prod- 
ucts of each assembly experiment were assayed by negative stain electron 
microscopy using 0.7%  aqueous uranyl acetate. 
Cell Culture 
Baby hamster kidney fibroblasts (BHK-21)  and  mouse 3T3  fibroblasts 
were grown on etched  grid  "locator" coverslips (Bellco  Biotechnology, 
Vineland,  N  J)  for  microinjection  studies  as  previously  described 
(Vikstrom et al., 1989; Vikstrom et al., 1992). Fibroblasts devoid of vimen- 
tin and all other cytoskeletal IF proteins were obtained from 18-d-old  vi- 
mentin  knockout embryonic cultures (kindly provided by Drs. Charles 
Babinet and Emma Colucci-Guyon of the Pasteur Institute, Paris, France). 
These  cells  were grown in  DME  (Sigma Immunochemicals, St.  Louis, 
MO) supplemented with 10% fetal calf serum (Hyclone Laboratories, Lo 
gan, UT) and antibiotics as previously described (Vikstrom et al.,  1989). 
In some cases, colchicine  (Sigma lmmunochemicals) was added  to 3T3 
cells at a concentration of 7.5 p~g/ml  culture medium to disassemble micro- 
tubules. 
Microinjection 
Cells were microinjected with the 1  A peptides dissolved in microinjection 
buffer (20 mM Tris, pH 8.0, 170 mM NaCI, 3 mM KC1) just before their 
use at final concentrations of 0.5-4.0  mg/ml. Microinjections were carried 
out on a Nikon inverted microscope (Melville, NY) equipped with either a 
Narishigi micromanipulator and injector (Greenvale, NY) or an Eppen- 
doff Micromanipulator 5171 and Transjector 5246 (Fremont, CA), using 
glass needles as previously described (Vikstrom et al.,  1989; Vikstrom et 
al., 1992). With the latter device, cells were injected  at a pressure of 32 hPa. 
The average volume of peptide solution injected  per cell  was deter- 
mined using published procedures (Lee,  1989; Minaschek et  al.,  1989). 
This involved the establishment of a standard curve generated by measur- 
ing  the  diameter  of  spherical  droplets  containing  10  Ixg  dextran- 
rhodamine  (dextran,  tetramethyl  rhodamine,  70,000 mol  wt  [4.9 mol 
rhodamine per mol dextran]; Molecular Probes, Eugene OR) per ml injec- 
tion buffer formed in Cargille  Type FF immersion oil (R.P.  Cargille  Labo- 
ratories, Inc., Cedar Grove, N J) and by determining the amount of fluo- 
rescence  per  droplet  using  the  method  described  by  Lee  (1989). 
Fluorescence images of each droplet were captured as quickly  as possible 
using a  Hamamatsu camera  (model  C2400  SIT; Bridgewater,  NJ)  and 
were stored in Image I (Universal Imaging Corp. West Chester, PA.). The 
total fluorescence intensity was determined for each drop using the "cali- 
brate total gray scale level" function. The volume for each droplet was de- 
termined by measuring its diameter with the Image I "measure with cali- 
per" function. The resulting data were used to establish a standard curve 
for volume versus total fluorescence intensity (Lee, 1989). Subsequently, 
3T3 or BHK cells grown on locator coverslips were microinjected with dif 
ferent concentrations of rhodamine-dextran in microinjection buffer using 
the Eppendorf system. Injected cells were first viewed with phase optics, 
and subsequently fluorescence images of live cells were "captured" as rap- 
idly  as possible and stored in Image I as described above. The Image I 
"measure  area  brightness" function  was  used  to  determine  the  total 
amount of fluorescence in each live cell. The results obtained following 
microinjection  of three  different  concentrations  of  dextran-rhodamine 
into 175 ceils showed that an average of 0.06 pl was delivered to each cell. 
Quantitation of Cytoskeletal Proteins 
in BHK and 3T3 Cells 
One dish of either confluent 3T3 or BHK cells was trypsinized,  rinsed twice 
with PBS, and split into two conical tubes. The cells in one tube were resus- 
pended in 2 ml of PBS, and the number of cells was determined with a hemo- 
cytometer. The other tube was centrifuged and resuspended in 0.5 ml of 
SDS  gel  electrophoresis sample  buffer  and  used  for  SDS-PAGE  and 
quantitative  Western immunoblotting analyses as  previously described 
(Wong and Cleveland, 1990). Since vimentin and actin are the most prom- 
inent bands in total cell lysates,  their quantities were estimated by com- 
paring densitometric scans of Coomassie blue-stained gel samples with 
different amounts of purified bacterially expressed human vimentin and 
chicken muscle actin  (a gift of Dr. Rex Chisholm, Northwestern Univer- 
sity, Chicago, IL) separated on the same gel. Gel scanning was carried out 
on an LKB 2222-010 UltroScan XL Densitometer (Pharmacia LKB Bio- 
technolgy Inc., Piscataway,  NJ). The tubulin concentration in the cell ly- 
sates was obtained by immunoblotting with a monoclonal antibody (N357; 
Amersham Corp. Arlington Heights, IL). Purified 6x bovine brain tubulin 
(Vallee,  1986; a  gift  of Dr. Christine Collins,  Northwestern University, 
Chicago, IL) was used as a standard in these assays. 
Microscopy 
After microinjection with a 1A peptide, cells on "locator" coverslips were 
fixed in methanol at -20°C for 5 minutes (Vikstrom et al., 1989) to visual- 
ize  IF and  microtubules. Upon removal from the methanol, cells  were 
washed in PBS at room temperature and processed for indirect immuno- 
fluorescence (Vikstrom et al., 1989) using either a rabbit antibody (Yang 
et al,  1985) or a  mouse monoclonal antibody directed  against vimentin 
(Sigma Immunochemicals). In some experiments, the mouse monoclonal 
antitubulin  (see  above)  was  used  to  visualize  microtubules,  and 
rhodamine-phalloidin (Molecular Probes) was used to visualize  actin.  In 
the latter case, cells were fixed in PBS for 5 min at RT, followed by 3 min 
in 0.1%  NP-40  in  PBS  and  washing in PBS.  Secondary antibodies  in- 
cluded goat anti-rabbit TRITC and goat anti-mouse FITC (Kirkegaard 
and Perry Labs, Inc., Gaithersburg, MD). Double labeling was carried out 
as described elsewhere (Yang et al., 1985). After staining with antibodies, 
coverslips were mounted in gelvatol (Yang et al., 1985) and examined with 
either a Zeiss LSM2 Confocal or Axiophot microscope (Thornwood, NY). 
Images were recorded on 35 mm film for conventional fluorescence or on 
an optical disk for confocal observations (Moir et al., 1994). A Phillips 400 
TEM (Mahwah, NJ) was used to examine the negative stain preparations 
and electron micrographs were taken on Kodak film (Rochester, NY). 
Results 
1A Peptides Interfere with Vimentin IF Assembly and 
Structure In Vitro 
When the 35-residue vimentin 1A peptide (See Materials 
and Methods) is added to a suspension of preformed IF in 
a 1:1 molar ratio in IF assembly buffer (AB), disassembly 
of the IF into small particles is seen within 30 min at room 
temperature. The overall structural features of this disas- 
sembly process can be monitored by taking samples from a 
reaction mixture at time intervals and preparing them for 
negative stain electron microscopy (Fig. 1, A-D). In paral- 
lel experiments using identical conditions, glutaraldehyde 
cross-linking demonstrates that the large oligomeric pro- 
tein complexes corresponding to intact IF are reduced to 
smaller oligomers containing primarily one to four protein 
chains  (Fig. 2). Taken together, the electron microscopic 
and cross-linking assays show that the 1A peptide induces 
the disassembly of vimentin IF in vitro. We have also car- 
ried out the reverse experiment to examine the assembly 
of vimentin IF in the presence of the vimentin 1A peptide. 
Goldman et al. Intermediate  Filaments and Cell Shape  973 Figure 1.  Electron microscopic analysis of the effects of the vimentin 1A peptide on polymerized vimentin IF. (A) Preformed vimentin 
IF in the absence of peptide. (B-D) Effects on vimentin IF after the addition of the 1A peptide at 1:1 molar ratios: (B) 5 min, (C) 10 min, 
(D) 30 min. (E) Effects of the 18-residue mutant R10H keratin 10 1A peptide on vimentin IF after 30 min. (F-H) Effects of the peptide 
on F-actin: (F) actin filaments in the absence of 1A peptide and (G) actin filaments assembled in the presence of a 3:1 molar ratio of 1A 
peptide: F-actin; (H), same as (G) followed by the addition of murine skeletal muscle heavy meromyosin. (/) Effects of a 3:1 molar ratio 
of vimentin IA peptide: tubulin. The peptide was added prior to the polymerization of microtubules. Negatively stained with 0.7% ura- 
nyl acetate. (A-H) Bar, 200 nm; (I) Bar, 100 nm. 
The  results  show  that  vimentin  oligomers maintained in 
low ionic strength buffers (AB devoid of KCI, see Materi- 
als and Methods) rapidly assemble into IF upon the addi- 
tion of KC1 to 0.15 M  (Steinert et al., 1981; Steinert et al., 
1993a).  However, in the presence  of a  1:1  molar ratio of 
peptide 1A, the assembly process is inhibited, resulting in 
the conversion of the predominantly tetrameric form of vi- 
mentin  in  solution to  largely monomeric  vimentin  (data 
not  shown).  Identical disassembly or assembly inhibition 
reactions are seen using the morphological and cross-link- 
ing assays with both full-length (35 residues) or half-length 
(18 residues) wild-type keratin 10 1A peptides at 1:1 molar 
ratios (data not shown). 
The fact that the inhibitory action of the 1A peptide on 
vimentin IF is retained in the first  18  residues of this se- 
quence  is  consistent  with  similar  studies  on  keratin  IF 
(Steinert et al., 1993c). On the other hand, the control ker- 
atin 10 1A peptide bearing an arginine to histidine (R10H) 
substitution corresponding to a  major site of mutation in 
either  the  keratin  10  or  14  chains,  which  causes  epider- 
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vimentin IF after mixing with 1:1 molar ratios of the vimentin 1A 
peptide. Aliquots were removed at the times indicated.  These 
were  immediately cross-linked  with  glutaraldehyde.  Molecular 
weight markers (M) using cross-linked keratin 10 chains (60-Kd) 
as previously  described  (Steinert et al., 1993a). Numbers at left 
refer to the size of oligomers. The large oligomeric products cor- 
responding to cross-linked intact vimentin IF at "0" time were re- 
duced to mostly single chains, dimers, and small oligomers within 
30 min (Steinert et al., 1993b). 
molytic hyperkeratosis  or  epidermolysis bullosa  simplex 
(Steinert  et  al.,  1993c),  respectively,  has  comparatively 
much less of an effect on the morphology of preformed vi- 
mentin IF at molar ratios of 1:1 (Fig. 1 E). The only appar- 
ent morphological alteration, even at 10-fold molar ratios 
of mutant peptide, is a  "rougher" appearance at the sur- 
face of IF perhaps revealing a slight "unraveling" of pro- 
tofilaments.  At  these  same  molar  ratios,  no  obvious 
changes in vimentin IF assembly or disassembly reactions 
could be detected by turbidity, cross-linking, or sedimen- 
tation analyses. The latter revealed that about 95% of the 
total protein remained pelletable. These results are similar 
to those obtained with keratin IF in vitro (Steinert et al., 
1993c). 
In further control experiments, we determined the over- 
all in vitro assembly properties of the other major cytoskel- 
etal proteins, microtubules and actin filaments, in the pres- 
ence of the wild-type and mutant 1A peptides. Assembly 
of murine epidermal G-actin into F-actin was unaffected 
by the inclusion of up to a 3:1 molar ratio of the wild-type 
vimentin 1A peptide (compare Figs. 1, F and G). The sub- 
sequent  decoration  of  the  peptide-treated  F-actin  by 
heavy meromyosin yielded the typical arrowhead configu- 
rations, indicating that the ability of F-actin to bind myosin 
was  unimpaired  (compare Figs.  1,  G  and  H).  Similarly, 
over 90% of murine brain tubulin that assembled into mi- 
crotubules in vitro was unaltered by inclusion of either the 
vimentin (Fig.  1 I), the full-length, or the mutant keratin 
10 1A peptides (not shown) at molar ratios of 3:1 (also as- 
sayed by turbidity; Steinert et al., 1993c).  At molar ratios 
exceeding 3:1, the yield of tubulin or actin in polymerized 
structures began to decrease slightly, and at 10.'1 ratios, ap- 
proximately 50% of these proteins remained polymerized. 
At molar ratios exceeding 5:1, the peptides interfered sig- 
nificantly with the buffering capacity of the solutions used 
for tubulin and actin assembly, which may help to explain 
the observed in vitro effects on microtubules and actin fil- 
aments. Together, these observations on microtubule and 
F-actin assembly in vitro, as well as the limited inhibitory 
effect of the mutant peptide on vimentin assembly in vitro, 
further emphasize that the 1A peptide has very specific ef- 
fects on IF assembly and structure. These data are of spe- 
cial  significance  when  viewed  in  light  of the  measured 
amounts  of  tubulin  and  actin  in  cells  relative  to  the 
amounts of microinjected peptide (see below). 
Microinjection of the 1A Peptides into Living Cells 
BHK-21  and  3T3  cells contain  an  extensive cytoplasmic 
network of polymerized Type III IF. In BHK cells, these 
networks consist mainly of vimentin with a lesser amount 
of desmin (Quinlan and Franke, 1982).  In 3T3 cells, only 
vimentin can be detected. Cells on locator coverslips were 
injected  with  several  concentrations  of  the  various  1A 
peptides dissolved in injection buffer and fixed for indirect 
immunofluorescence with vimentin antibody at time inter- 
vals after injection. At concentrations below 0.5 mg/ml, no 
obvious effects could  be detected  with  the  vimentin  1A 
peptide. In the 0.5-2.0 mg/ml range, BHK cells exhibited a 
variety of changes ranging from very subtle to more obvi- 
ous.  The  majority  of  injected  cells  showed  small  alter- 
ations in shape that were correlated with a  localized con- 
version of the IF staining pattern from a more filamentous 
state to a  more diffuse one, within  15-60 min post-injec- 
tion. These changes in IF structure were especially evident 
at the cell periphery and were coincident with varying de- 
grees of retraction of the cell borders (data now shown). 
More rapid, obvious, and consistent changes were seen 
in the majority of BHK cells after microinjection of the vi- 
mentin 1A peptide at concentrations of 2-4 mg/ml. The ex- 
tensive cytoplasmic IF networks normally seen by indirect 
immunofluorescence  with  vimentin  antibody  (Fig.  3  A), 
changed within minutes after microinjection. Initially, the 
normal IF pattern was altered to a  less filamentous state 
(Fig. 3, B and C), subsequently appearing to become frag- 
mented into bright spots, short rod-like structures, and ir- 
regularly shaped  structures  within  15-30  min  (Fig.  3,  D 
and  E).  The  latter  patterns  vary from cell  to  cell.  Ulti- 
mately, all cells look approximately the same, as these var- 
ious  vimentin-rich  structures  aggregate near the  nucleus 
coincident  with  alterations  in  their  shape  from  a  fully 
spread configuration  to  a  rounded  one  (Fig.  3  F).  Simi- 
larly, individual live cells followed by phase contrast dur- 
ing  this  IF  disassembly  process  dramatically  alter  their 
shape from the typical asymmetric configuration of a fully 
spread  fibroblast  to  a  cell  with  a  rounded  morphology 
(Fig. 4, A-C). The latter cells frequently exhibit extensive 
surface blebbing (Fig. 4  D). A  variable fraction of these 
rounded cells lose their adhesions to their substrates and 
float away, and others that are tenuously adherent to the 
coverslips are lost during fixation and processing for indi- 
rect immunofluorescence. However, the majority remain 
following  fixation  and  processing.  Of 319  cells  injected, 
80%  appeared as in Fig. 4, C  and D.  Other cells showed 
varying  responses,  most  likely  due  to  variations  in  the 
amount of peptide injected. (See Minaschek et al., 1989 for 
a detailed discussion of the difficulties involved in the in- 
Goldman et al. Intermediate  Filaments  and Cell Shape  975 Figure 3.  (A) Uninjected BHK-21 cell fixed and stained for indirect immunofluorescence  with vimentin  antibody. (B-F) BHK cells ob- 
served at approximately 15 (B), 20 (C), 30 (D), 45 (E), and 60 (F) min after injection with the vimentin 1A peptide. All cells fixed and 
stained for indirect immunofluorescence  with vimentin  antibody. Bars, 25 v~m. 
jection of known amounts of solutions into cells.) Identical 
results were obtained for 3T3 cells, which were more sensi- 
tive to the peptides. Maximum effects on IF network disas- 
sembly and cell shape were seen in 15-30 min at concen- 
trations  of  0.5-2.0  mg/ml  (data  not  shown  as  the  cells 
appear identical to  those  seen in Fig. 3).  The effects on 
3T3 cells were reproducible within the same time frame as 
observed for BHK cells. At a concentration of 0.5-2.0 mg/ml, 
90% (n =  137) of the 3T3 cells appeared as in Fig 4, C and D. 
After 1-3 h, cells which had been induced to round-up 
after injection of the peptide began to recover their nor- 
mal morphology, and this was  coincident with the  reap- 
pearance of normal IF networks. Initially, this rapid rever- 
sal made it difficult to determine the more dramatic effects 
The Journal  of Cell Biology, Volume 134, 1996  976 Figure 4.  (A-C) A series of micrographs of a live 3T3 cell before injection (A), 20 min after injection (B), and 30 min after injection (C) 
as seen by phase contract optics. (D) By 30-45 min, the majority of cells appear rounded and exhibit extensive surface blebbing. (E and 
F) The same cell observed at 4 h after injection of the vimentin 1A peptide. This cell had rounded up and then respread on the cover- 
slip. Subsequently it was fixed and stained for indirect immunofluorescence with vimentin antibody. (A-C, E, and F) Bars, 25 ~m; (D) 
Bar, 5 txm. 
of the peptide injections because our pilot experiments in- 
volved monitoring  cells  beginning  at  1  h  after  injection. 
Recovery of normal  IF networks  and cell shape was ob- 
served between 3-6 h after injection (Fig 4, E  and F). 
A  series of microinjection experiments were also carried 
out with the other 1A peptides  (see Materials  and Meth- 
ods). Both the wild-type keratin 10 1A full-length and half- 
length peptides were equally effective at concentrations of 
2-4 mg/ml in BHK cells and 0.5-2 mg/ml in 3T3 cells. The 
cells  exhibited  changes  that  were  indistinguishable  from 
those seen with the vimentin 1A peptide (see Figs. 3 and 4). 
As a control, the keratin 10 1A peptide bearing the single 
amino  acid substitution  R10H  (see  Materials  and  Meth- 
ods)  was  microinjected  at  the  same  concentrations  into 
Goldman et al. Intermediate  Filaments and Cell Shape  977 BHK and 3T3 cells. No obvious effects on IF organization 
or ceil shape could be detected for up to 2-4 h of observa- 
tion after injection (not shown because injected cells pos- 
sess IF patterns similar to those seen in Fig. 3 A). 
Due to the dramatic effects of the wild-type 1A peptides 
on IF assembly and cell shape, we also carried out obser- 
vations on the other major cytoskeletal systems, microtu- 
bules and actin-containing microfilaments. Indirect immu- 
nofluorescence  revealed  that  microtubules  decreased  in 
number coincident with the alterations in the IF network 
and cell shape. Only a few short microtubules (or none at 
all) could be resolved in rounding up BHK or 3T3 cells ob- 
served at 30 min after the microinjection of the vimentin 
1A peptide at concentrations of 2-4 mg/ml or 0.5-1 mg/ml, 
respectively. In the rounded cells, small spots surrounded 
by a diffuse fluorescence background could be seen as de- 
tected by indirect immunofluorescence with tubulin  anti- 
body (Figs.  5, A-C).  In the  case  of actin-containing  mi- 
crofilaments,  stress  fibers  appeared  to  disassemble  into 
large fluorescent  aggregates as cell rounding  progressed 
(Figs. 5, D-F). These effects on microtubule and microfila- 
ment  patterns  were  also  reversed  within  a  few  hours. 
Based on morphological criteria, their reassembly also ap- 
peared to be coincident with the  reestablishment of cell 
shape and the normal appearance of the IF network.  In 
the case of ceils injected with the mutant peptide, no obvi- 
ous alterations in the distribution  of microtubules or mi- 
crofilaments were seen at the concentrations tested. 
Several  additional  controls  for the  specific binding  of 
the vimentin 1A peptides to IF and not to microtubules or 
microfilaments were undertaken.  Cells were observed at 
short time intervals after injection and processing for dou- 
ble-label immunofluorescence with tubulin  and vimentin 
antibodies.  Typically, after 5-15  min,  the  peripheral  re- 
gions of cells were devoid of IF, but extensive arrays of mi- 
crotubules remained (Fig. 5, G and H). This suggested that 
the effect of the peptide was to first destabilize vimentin 
IF and  subsequently  to  destabilize  the  microtubules re- 
maining in  the peripheral regions of the  cytoplasm. 3T3 
cells were also treated with colchicine for short time inter- 
vals in order to disassemble microtubules. After 30 min of 
colchicine treatment, these cells retained a network of IF, 
most  of which  remained  dispersed  between  the  nucleus 
and the cell surface. These cells contained very few assem- 
bled microtubules, and they remained well spread on the 
substrate with little or no obvious change in shape (Fig. 6, 
A-C). When injected with the 1A peptide in the concen- 
tration range of 0.5-2  mg/ml, the cells rapidly disassem- 
bled their IF networks and rounded up in the same fashion 
as seen in Figs. 3 and 4 (data not shown). 
Since the injection of the 1A peptides had pleiotropic ef- 
fects in live cells, especially with respect to alterations in 
the other cytoskeletal systems, it became important to esti- 
mate  the  relative  amounts  of peptide  injected  per  cell 
compared to the endogenous concentrations of vimentin, 
actin, and tubulin. To this end, we have approximated the 
in vivo molar ratios by first calculating that the  average 
volume of solution injected into 3T3 and BHK cells is .06 pl 
(see Materials and Methods). In the case of 3T3 cells, in- 
jection at a concentration of 0.5  mg/ml vimentin 1A pep- 
tide  is equivalent to 0.007  fmol per cell.  We have calcu- 
lated that there is an average of 0.153 fmol vimentin, 0.007 
fmol tubulin, and 0.443 fmol actin per 3T3 cell. Therefore 
the molar ratios of peptide/cytoskeletal protein are 1:20 for 
vimentin, 1:1 for tubulin, and 1:64 for actin. For the shorter 
peptides, the molar ratios at the same concentration of 0.5 
mg/ml would be approximately 1:10 for vimentin, 2:1  for 
tubulin, and 1:32 for actin. A  concentration of 2 mg/ml vi- 
mentin  1A  peptide  is equivalent  to  0.028  fmol per cell, 
yielding  approximate peptide/cytoskeletal  protein  molar 
ratios of 1:5 for vimentin, 4:1 for tubulin, and 1:16 for ac- 
tin.  A  similar range  of molar ratios  relative  to  average 
amounts of injected peptides was obtained for BHK cells. 
However, these cells require more peptide to achieve the 
same in vivo results. This appears to be accounted for by 
the fact that in BHK cells, there is about 30--40% more IF 
protein due to the presence of desmin (data not shown). 
As a further control, we injected the vimentin 1A pep- 
tide into vimentin-free fibroblasts derived from vimentin 
knockout mice (Fig. 7, A and B). At concentrations of 0.5- 
1.0 mg/ml of the vimentin 1A or the two K10 1A peptides, 
no significant alterations in cell shape could be detected in 
injected cells. A  few cells showed partial retraction in the 
region of the needle puncture immediately following injec- 
tion, but 85% (n =  221) retained their shape with no obvi- 
ous alterations in either microtubule or actin-stress fiber 
arrays (Fig. 7, C and D). Unlike normal fibroblasts, these 
cells were extremely fragile and great care had to be taken 
for successful injections. These observations further dem- 
onstrate the specific targeting of the 1A peptides to inter- 
mediate filaments and not other cytoskeletal constituents. 
Discussion 
In Vitro Studies 
In vitro studies demonstrate that at 1:1 molar ratios, helix 
initiation  1A peptides induce the rapid and efficient con- 
version of polymerized IF into small oligomeric and mo- 
nomeric protein chains, using either the vimentin or kera- 
tin  10  1A  peptides.  The finding  that both vimentin  and 
keratin 1A peptides are equally effective in depolymeriz- 
ing vimentin IF is most likely related to the fact that the 
1A domain is one of the most highly conserved domains 
involved in IF structure (Steinert et al., 1993a; Steinert et al., 
1993c;  Parry and Steinert,  1995).  The specificity of these 
effects on IF in vitro is supported by experiments with the 
keratin  10 mutant  1A peptide containing a  single  amino 
acid substitution,  R10H.  At the same or excess ratios of 
mutant peptide to vimentin IF, relatively little effect on IF 
structure is detected.  The findings that wild-type or mu- 
tant peptides only induce significant microtubule or F-actin 
structural changes at high molar excesses support their use 
as specific disruptors of IF structure in vivo. 
Presumably, the peptides act by binding to the same se- 
quences on the intact protein chains comprising polymer- 
ized IF, thereby causing destabilization and eventual col- 
lapse of IF structure. Interestingly, the 1A helix initiation 
peptide is more destructive in vitro than the 2B helix ter- 
mination peptide and about as equally destructive as the 
H1 peptide in the case of keratin IF (Chipev et al., 1992). 
However, the H1 peptide has little or no effect on vimen- 
tin IF in vitro or in vivo (data not shown), in sharp contrast 
The Journal of Cell Biology, Volume 134,  1996  978 Figure 5.  (A-C) Indirect immunofluorescence  observations of microtubule patterns in BHK cells before (A) and at time intervals fOl- 
lowing microinjection with peptide 1A: (B) 15 min, and (C) 30 min. (D-F) Fluorescence observations of changes in actin patterns ~ 
cells round up after microinjection  with 1A peptide. Cells were fixed and stained with rhodamine-phaUoidin.  Note conversion of p!~o0~i.- 
nent stress fibers into a primarily diffuse pattern. (D) Before injection, (E) 15 min after injection, and (F) 45 min after injection.  (G-H) 
BHK cell observed at 5 min after injection and subsequently fixed and double labeled with vimentin (G) and tubulin (H) antibodies. 
Note that the majority of vimentin antibody staining has disappeared to the left of the nucleus in G, while numerous microtubules .a~e 
seen in the same region. Bars, 25 I~m. 
Goldman  et al. Intermediate Filaments and Cell Shape  979 Figure 6.  BHK cell treated with colchicine for 30 min and then fixed and stained for double indirect immunofluorescence with vimentin 
antibody (A) and tubulin antibody (B). (C) The same cell in phase contrast. Note that the overall shape and the degree of cell spreading 
is not altered significantly  in the absence of microtubules. Bars, 25 I~m. 
to its effect on keratin IF (Chipev et al., 1992).  Other mi- 
metic peptides derived from other domains of keratin IF 
polypeptide chains  have  also  been  studied  in  vitro,  but 
most have  not been effective in inducing  IF disassembly 
(Steinert et al., 1993a). Although the use of a variety of mi- 
tactic  peptides  has  provided  important  insights  into  IF 
structure in vitro, many of the peptides studied to date are 
not particularly useful for in vivo studies as they must be 
used at excessive molar ratios of peptide to polymer. It is 
precisely for this reason that we have chosen the helix ini- 
Figure 7.  (A and B) Same vi- 
mentin-free  cell  observed 
with phase contrast (A) and 
fluorescence optics (B). The 
cell was fixed and stained for 
indirect  immunofluorescence 
with vimentin antibody. (C) 
Cell observed at 45 min after 
injection with 1A peptide fol- 
lowing fixation and  staining 
with antitubulin. (D) Cell ob- 
served at 45 min after injec- 
tion of 1A peptide following 
fixation  and  staining  with 
rhodamine  phalloidin.  Bars, 
25 ixm. 
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the most potent at the lowest molar ratios tested in vitro 
(Steinert et al., 1993c). 
In Vivo Studies 
The rationale for the in vivo studies stems from recent evi- 
dence demonstrating that  IF exist in  a  state  of dynamic 
equilibrium (Vikstrom et al., 1992; Miller et al., 1993). This 
suggests that we should be able to use the 1A peptides to 
bind and "capture" exchangeable subunits, rendering them 
nonexchangeable and thereby acting as  targeted disrup- 
tors of IF structure. The microinjection results described 
in this study support this contention. 
A major concern regarding the use of the peptides is re- 
lated to their concentrations in vivo after microinjection. 
Even though  the  1A peptide effects can be titered pre- 
cisely in vitro, it is difficult to determine equivalent molar 
ratios in vivo, because of the inherent inaccuracies of the 
microinjection procedure. However, the finding that the 
average effective peptide concentrations required for IF 
disruption in vivo are equivalent to less than the 1:1 molar 
ratios used in vitro supports their specificity and targeting 
to IF. Further support for the targeting of the 1A peptide 
primarily to IF and not to microtubules or microfilaments 
is  derived both  from the  results  with  colchicine-treated 
cells  and  the  rapid  response  of IF  to  the  1A  peptides 
shortly after microinjection when  microtubules  and  mi- 
crofilaments appear to remain intact (see Figs. 5, G and H, 
and 6).  The controls employing the mutant peptide  and 
the lack of response in the vimentin free fibroblasts also 
support  the  use  of the  1A  peptides  as  inhibitors  of IF 
structure and function. Most likely, the peptides disrupt IF 
structure in vivo by the breakage of IF polymers into oli- 
gomeric  complexes.  In  support  of this,  electron micro- 
scopic observations indicate that relatively very few intact 
IF can be seen in 3T3 cells at 30 min after injection of the 
vimentin 1A peptide (unpublished observations). 
Other  approaches  have  also  been  used  to  perturb  IF 
networks in vivo (see Introduction). These include colehi- 
cine  treatment  (Goldman  and  Knipe,  1973;  Green  and 
Goldman, 1986; Yang et al., 1992), antivimentin injections 
(Klymkowsky, 1981), heat shock (Welch and Suhan, 1985), 
the microinjection of protein kinase A (Lamb et al., 1989), 
and the microinjection of kinesin antibodies (Gyoeva and 
Gelfand, 1991).  In each of these experimental situations, 
vimentin IF are reorganized within the cytoplasm to form 
large aggregates, but they appear to remain polymerized 
and cell shape  is  not significantly altered.  On  the  other 
hand, the disassembly of vimentin IF with the 1A peptides 
does have a dramatic effect on cell shape, the overall in- 
tegrity  of other  cytoskeletal systems,  and  the  adhesive 
properties of cells. Further support for the role of IF in cell 
shape  and adhesion is  derived from studies of blistering 
diseases  of  the  skin  in  which  keratinocytes  alter  their 
shape and intercellular contacts in concert with the occur- 
rence of keratin mutations that induce the clumping and 
breakage  of  bundles  of  keratin-IF  (Anton-Lamprecht, 
1983;  Williams  and  Elias,  1987;  Coulombe  et  al.,  1991; 
Ishida-Yamamoto et al., 1991, 1992). The majority of these 
mutations are in the 1A helix initiation region (Fuchs et al., 
1994; Steinert et al., 1994; Parry and Steinert, 1995). A role 
for glial IF in cell shape has also been demonstrated in cul- 
tured astrocytes (Weinstein et al., 1991). 
The importance of cytoskeletal IF in maintaining cyto- 
plasmic and mechanical integrity is supported by in vitro 
analyses demonstrating that the viscoelastic properties of 
vimentin IF are distinctly different from those exhibited 
by microtubules and F-actin (microfilaments). Compara- 
tive studies show that vimentin IF are unique in that they 
are less rigid at low strain and become much more rigid at 
high  strain  forces that  disrupt  F-actin  and  microtubules 
(Janmey et al., 1991). It is due to this property of "harden- 
ing" at high strains that has led to the conclusion that IF 
are  the  cytoskeletal  elements  most  responsible  for  the 
maintenance of "cell integrity" (Janmey et al., 1991). The 
fact that the vimentin-free cells used in this study appear 
to be extremely fragile with respect to their ability to toler- 
ate a micropuncture also supports this possibility. 
The changes in  cell shape  accompanying the  peptide- 
induced disassembly of vimentin IF networks are also in- 
triguing in light of the coincident destabilization of micro- 
tubules and microfilaments. Since the minimum effective 
doses of peptide used in vivo are below those required to 
obtain significant changes  in  microtubule and/or F-actin 
polymerization in vitro, it appears likely that the disrup- 
tion of vimentin IF leads to the destabilization of the other 
cytoskeletal constituents. 
The destabilization of other cytoskeletal components is 
not surprising if one considers the morphological, physio- 
logical, and biochemical data supporting associations be- 
tween  microtubules  and  IF  (for  reviews  see  Goldman, 
1971; Goldman et al., 1980; Yang et al., 1992) and between 
microfilaments  and  IF  (Hubbard  and  Lazarides,  1979; 
Green et  al.,  1986).  For  example,  microtubules  exist  in 
parallel and most likely cross-bridged arrays in fibroblasts 
(Goldman and Knipe, 1973) and in neurons (Runge et al., 
1981).  Furthermore,  virtually  all  inhibitors  which  disas- 
semble microtubules also induce the reorganization of vi- 
mentin  and other Type III IF (see e.g., Goldman,  1971; 
Yang et al.,  1992), indicating that these two cytoskeletal 
systems are interactive. These interactions may involve IF- 
associated proteins (IFAPs;  Yang et al.,  1992), microtu- 
bule-associated and motor proteins (LeTerrier et al., 1982; 
Bloom and Vallee, 1983; Gyoeva and Gelfand, 1991), as 
well  as  direct interactions between  IF subunit  proteins, 
such as Type IV NF-H, and microtubules (Hisanaga et al., 
1993).  Interactions between IF and  microfilaments have 
been  described in  detail in  cultured cells  (Green et  al., 
1986; Hollenbeck et. al.,  1989).  In support of this, it ap- 
pears that the COOH-terminal domain of vimentin can as- 
sociate with actin (Cary et al., 1994), and a gene has been 
described that encodes a protein with potential actin and 
IF-binding domains (Brown et al., 1995). 
Based on the apparent importance of the expression of 
vimentin in early development (Tapscott et al., 1981) and 
the deleterious effects seen in transgenic mice which over- 
express vimentin (Capetanaki et al.,  1989), it is surprising 
that no obvious phenotypes have been reported in vimen- 
tin  gene  knockout  mice  (Colucci-Guyon  et  al.,  1994). 
There are no straightforward explanations for this result. 
However, it is possible that one cytoskeletal system might 
be able to compensate for another, at least to an extent 
necessary for overall cell survival. An indication that this 
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blasts of the vimentin-free mouse used in this study. These 
cells contain remarkably  complex arrays of microtubules 
and actin-containing stress fibers for early passage embry- 
onic cultures (Fig. 7). Further support for the existence of 
cytoskeletal compensation is derived from the observation 
that after colchicine treatment, there is an increase in the 
number and prominence of stress fibers  (Goldman, 1971; 
unpublished observations)  and that tubulin expression is 
upregulated in mice  lacking the NF-L gene  (Julien, J.P., 
personal  communication).  Furthermore,  the  finding that 
the vimentin-free fibroblasts are extremely fragile with re- 
spect to microinjection suggests that the mechanical prop- 
erties of these cells are abnormal. In this regard, more ex- 
tensive studies determining the viscoelastic  properties  of 
live vimentin-free  cells should be undertaken (see Wang 
et al., 1993). Alterations  in such properties  are to be ex- 
pected from the in vitro analyses of the mechanical prop- 
erties of IF relative to other cytoskeletal polymers (Jan- 
mey et al., 1991). 
In summary, we have presented  evidence that  the  1A 
helix initiation peptides are useful tools for the disruption 
of vimentin  IF  both in vitro  and  in  vivo.  The  data pre- 
sented  demonstrate  that in cells  which express  vimentin, 
the resulting IF polymer plays central and important roles 
in cell shape, in the maintenance of the overall integrity of 
cytoplasm, and in stabilizing cytoskeletal interactions and 
cell substrate adhesions. We are now using these and other 
mimetic peptides to attempt to delve into the functions of 
other IF systems. The preliminary results in epithelial cells 
containing  keratin  and  in  neurons  containing  Type  IV 
neurofilaments indicate that the use of peptides  targeted 
to specific subdomains of IF will continue to provide very 
important  insights  into  their  specific  functions  in  living 
cells. 
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